Spectrum of factor IX gene mutations causing haemophilia B from India

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 5, 2009, Pages 333-336

  Ghosh, Kanjaksha ^a   Quadros, Leera ^a   Shetty, Shrimati ^a  

^a KEM HOSPITAL   (India)

Author keywords

Haemophilia B; India; Mutations

Indexed keywords

BLOOD CLOTTING FACTOR 9;

ARTICLE; CATALYSIS; DNA SEQUENCE; ENZYME ACTIVE SITE; EXON; GEL ELECTROPHORESIS; GENE DELETION; GENE MUTATION; GENETIC SCREENING; HEMOPHILIA B; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

CATALYTIC DOMAIN; DNA MUTATIONAL ANALYSIS; EXONS; FACTOR IX; GENETIC HETEROGENEITY; GENETIC SCREENING; HAPLOTYPES; HEMOPHILIA B; HUMANS; INDIA; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 68149108646     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832b27d1     Document Type: Article

References (18)

1. Belvini D, Salviato R, Radossi P, Pierobon F, Mori P, Castaldo G, Tagariello G, AICE HB Study Group. Molecular genotyping of the Italian cohort of patients with hemophilia B. Haematologica 2005; 90:635-642.
2. Klein I, Andrikovics H, Bors A, Nemes L, Tordai A, Váradi A. A haemophilia A and B molecular genetic diagnostic programme in Hungary: a highly informative and cost-effective strategy. Haemophilia 2001; 7:306-312.
3. Peake IR, Lillicrap DP, Boulyjenkov V, Briet E, Chan V, Ginter EK, et al. Haemophilia: strategies for carrier detection and prenatal diagnosis. Bull World Health Organ 1993; 71:429-458.
4. Jayandharan GR, Shaji RV, Chandy M, Srivastava A. Identification of factor IX gene defects using a multiplex PCR and CSGE strategy: a first report. J Thromb Haemost 2003; 1:2051-2054.
5. Jayandharan GR, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava A. Molecular characterization of factor IX gene mutations in 53 patients with haemophilia B in India. Thromb Haemost 2005; 94:883-886.
6. Mahajan A, Chavali S, Kabra M, Chowdary MR, Bharadwaj D. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene. Haematologica 2004; 89:1498-1503.
7. Mahajan A, Sharma A, Chavali S, Kabra M, Chowdary MR, Srinivasan N, Bharadwaj D. Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B-Factor IXDelhi. Haemophilia 2004; 10:550-552.
8. Mahajan A, ChavaliS, GhoshS, KabraM,Chowdary MR, Bharadwaj D, The Indian Genome Variation Consortium. Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Hum Mutat 2007; 28:526-1526.
9. Mukherjee S, Mukhopadhyay A, Banerjee D, Chandak GR, Ray K. Molecular pathology of haemophilia B: identification of five novel mutations including a LINE 1 insertion in Indian patients. Haemophilia 2004; 10:259-263.
10. Dacie JV, Lewis SM. In Practical hematology, 7th ed. UK: Churchill Livingstone; 1991.
11. Sambrook J, Russell DW. Molecular cloning, a laboratory manual, 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Press; 2001.
12. Williams IJ, Abuzendah A, Winship PR, Preston FE, Dolan G, Wright J, et al. Precise carrier and prenatal diagnosis in families with hemophilia A. Use of conformation sensitive gel electrophoresis for rapid mutation screening and polymorphism analysis. Thromb Haemost 1998; 79:723-726.
13. Quadros L,Ghosh K,ShettyS. AcommonG10430Amutation (Gly 60 Ser) in the factor IX gene describes the presence of moderate and mild hemophilia B in the majority of the Gujarati population. Ann Hematol 2007; 86:377-379.
14. Ketterling RP, Bottema CD, Phillips JA 3rd, Sommer SS. Evidence that descendants ofthree founders constitute about 25% of hemophilia B in the United States. Genomics 1991; 10:1093-1096.
15. Montandon AJ, Green PM, Bentley DR, Ljung R, Kling S, Nilsson IM, Giannelli F. Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and the ratio of the sex-specific mutation rates in Sweden. Hum Genet 1992; 89:319-322.
16. Xie YG, Zheng H, Leggo J, Scully MF, Lillicrap D. A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A. Thromb Haemost 2002; 87:178-179.
17. Koeberl DD, Bottema CD, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS. Mutations causing haemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions and deletions in a human gene. Am J Hum Genet 1990; 47:202-217.
18. Wacey AI, Krawczak M, Kakkar VV, Cooper DN. Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multidomain molecular model of the activated protein. Hum Genet 1994; 94:594-608.